Insider Trading & Ownership - Adjuvant Global Health Technology Fund DE L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Adjuvant Global Health Technology Fund DE L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-16
Sale
2024-01-18
6:18 pm
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
100,000$19.65$1,965,0002,373,500
(Indirect
Direct)
View
2023-11-14
Sale
2023-11-16
6:59 pm
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
1,810$16.15$29,2242,473,500
(Indirect
Direct)
View
2023-09-29
Sale
2023-10-03
7:13 pm
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
104,773$16.27$1,704,5132,475,310
(Indirect
Direct)
View
2023-09-27
Sale
2023-09-29
5:41 pm
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
9,357$16.11$150,7082,580,083
(Indirect
Direct)
View
2023-09-13
Sale
2023-09-15
5:17 pm
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
400$16$6,4002,589,440
(Indirect
Direct)
View
2023-09-06
Sale
2023-09-08
4:59 pm
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
7,140$16.03$114,4842,589,840
(Indirect
Direct)
View
2023-08-23
Sale
2023-08-25
4:31 pm
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
400$16$6,4002,596,980
(Indirect
Direct)
View
2022-03-29
Purchase(A)
2022-06-24
4:51 pm
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
166,666$15$2,499,9902,597,380
(Indirect
Direct)
View
2022-03-29
Purchase
2022-03-31
8:15 pm
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
10% Owner
166,666$15$2,499,9902,210,735
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-06
Other
2022-06-24
5:06 pm
N/A
N/A
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
26,511$152,650,402
(Direct)
View
2022-03-29
Conversion(A)
2022-06-24
4:51 pm
N/A
N/A
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
2,430,714$02,597,380
(Direct)
View

Ownership(A)
2022-06-24
4:48 pm
N/A
N/A
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
Adjuvant Capital GP L.P.
Adjuvant Capital Management LLC
10% Owner
0$02,430,714
(Direct)
View
2022-03-29
Conversion
2022-03-31
8:15 pm
N/A
N/A
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
10% Owner
2,430,714$02,210,735
(Indirect)
View

Ownership
2022-03-24
9:16 pm
N/A
N/A
AN2 Therapeutics Inc.ANTXAdjuvant Global Health Technology Fund L.P.
Adjuvant Global Health Technology Fund DE L.P.
10% Owner
0$02,430,714
(Indirect)
View
(A) Indicate amendment filing.